eFFECTOR Therapeutics’ Merger with Locust Walk Acquisition Corp.

Latham & Watkins LLP represented eFFECTOR in the transaction,eFFECTOR Therapeutics, Inc. (eFFECTOR), a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors (STRIs)…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now